Teva has ceased supply of all strengths of Beclazone Easi-Breathe (beclometasone dipropionate) inhalers, in line with the Montreal Protocol requirement for all CFC-containing beclometasone products to be phased out by 2010.
Qvar Easi-Breathe and Salamol Easi-Breathe are unaffected. Patients using Beclazone Easi-Breathe will need to be transferred to a suitable alternative.
Further information: Teva